5 Companies in Focus After Posting Their Financial Results
In this article, we discuss the 5 companies in focus after posting their financial Results.
Array Biopharma Inc (ARRY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 0 | $0 | 0% | |
| 2. | Quantamental Technologies Ran Pang | 0 | $0 | 0% | |
| 3. | Perceptive Advisors Joseph Edelman | 0 | $0 | 0% | |
| 4. | CSat Investment Advisory Claes Fornell | 0 | $0 | 0% | |
| 5. | Cormorant Asset Management Bihua Chen | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.20 | 5,000 | 8,000 | 2019-02-19 | Filing | ||
| $16.87 | 3,000 | 3,000 | 2018-11-01 | Filing | ||
| $3.50 | 28,000 | Large Shareholder | 19,150,650 | 2016-09-15 | Filing | |
| $3.51 | 372,000 | Large Shareholder | 19,129,950 | 2016-09-14 | Filing | |
| $3.19 | 300,000 | Large Shareholder | 19,150,650 | 2016-01-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.51 | 100,000 | 209,543 | 2019-06-04 | Filing | ||
| $27.58 | 36,134 | 209,543 | 2019-06-03 | Filing | ||
| $27.50 | 15,728 | 209,543 | 2019-05-30 | Filing | ||
| $27.00 | 74,915 | 209,543 | 2019-05-28 | Filing | ||
| $26.50 | 40,634 | 237,692 | 2019-05-23 | Filing |
Institutional Investors' Holdings
News See All
Here’s Why ClearBridge Disposed its Array Technologies (ARRY) Position
ClearBridge Investments, an investment management firm, published its “Sustainability Leaders Strategy” second quarter 2021 investor letter – a copy of which can be downloaded here.
Is Array Technologies (ARRY) A Good Stock To Buy Now?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Here’s Why Baron Funds Reduced its Array Technologies (ARRY) Position
Baron Funds, an asset management firm, published its “Baron Small Cap Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Is Array Biopharma Inc (ARRY) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
10 Best Growth Stocks to Buy and Hold for Several Years
In this article we will take a look at the 10 best growth stocks to buy in 2021 and hold for several years to come.
Is Array Technologies (ARRY) A Great Stock to Invest In?
ClearBridge Investments, an investment management firm, published its “Sustainability Leaders Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here.
Here’s Why Artisan Small Cap Purchased Array Technologies (ARRY)
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here.
Baron Funds Remains Optimistic in Array Technologies (ARRY), Here’s Why
Baron Funds, an asset management firm, published its “Baron Small Cap Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
10 Best New Stocks To Buy Now
Let’s face it: investing isn’t as easy as it seems, especially in the age of meme stocks, outrageous speculations and soaring valuations.
Billionaire Hedge Funds
